-
Converting existing cigarette factory in Greece into a production
facility for the tobacco sticks to be used with IQOS.
-
Annual capacity of around 20 billion tobacco sticks once fully
operational.
-
400 new jobs to be created.
LAUSANNE, Switzerland--(BUSINESS WIRE)--Mar. 22, 2017--
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today
announced an investment of approximately €300 million to convert the
cigarette factory of Papastratos, PMI’s affiliate in Greece, into a
manufacturing plant for the tobacco sticks to be used with its
smoke-free product IQOS. These tobacco sticks are currently
commercialized as Heets or HeatSticks.
Since the equipment necessary to manufacture tobacco sticks for
IQOS is larger than that required for cigarette manufacturing, the
current facility area will be expanded. Once fully operational, the
plant will have an annual capacity of around 20 billion tobacco sticks.
The investment will create 400 new jobs at Papastratos, which
already employs approximately 800 people. Construction on the site will
commence immediately, with production scheduled to begin in January 2018.
“This investment is further evidence of our progress towards a
smoke-free future. We are encouraged by the 1.4 million smokers who have
already switched to IQOS around the world, and we expect this momentum
to continue. This facility will help enable us to meet growing demand
from adult smokers,” stated Frederic de Wilde, PMI’s Regional
President for the European Union. He added, “Our ambition is that one
day potentially less harmful, smoke-free products replace cigarettes to
the benefit of smokers, public health, and society at large.”
The Papastratos plant in Aspropyrgos (Greece) will be PMI’s third
facility fully dedicated to the manufacture of smoke-free products. In
October 2016, PMI announced completion of its first facility for tobacco
sticks manufacturing in Crespellano (Bologna, Italy) in addition to a
pre-existing small scale Industrial Development Center in Neuchatel
(Switzerland).
IQOS is one of four smoke-free product types from PMI to address
adult smoker demand for potentially less harmful alternatives to
cigarettes. It is a heated tobacco product launched in late 2014 in two
city test markets and is expected to be available in key cities in over
30 markets in 2017. Since 2008, PMI has hired more than 400 scientists
and experts and invested over USD 3 billion in research, product
development, and scientific substantiation. Results of scientific
research to assess the reduced-risk potential of IQOS are very
promising, and the company openly shares its scientific methodologies
and findings for independent third-party review and verification.
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the world’s leading
international tobacco company, with six of the world's top 15
international brands and products sold in more than 180 markets. In
addition to the manufacture and sale of cigarettes, including Marlboro,
the number one global cigarette brand, and other tobacco products, PMI
is engaged in the development and commercialization of Reduced-Risk
Products (RRPs). RRPs is the term PMI uses to refer to products that
present, are likely to present, or have the potential to present less
risk of harm to smokers who switch to these products versus continued
smoking. Through multidisciplinary capabilities in product development,
state-of-the-art facilities, and industry-leading scientific
substantiation, PMI aims to provide an RRP portfolio that meets a broad
spectrum of adult smoker preferences and rigorous regulatory
requirements. For more information, see www.pmi.com
and www.pmiscience.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170322005541/en/
Source: Philip Morris International
Media enquiries
Philip Morris International Media Office
T:
+41 (0)58 242 4500
E: media@pmi.com